40164_2019_138_MOESM2_ESM.docx (36.85 kB)
MOESM2 of Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
journal contribution
posted on 2019-07-03, 05:00 authored by Ravi Potluri, Sandip Ranjan, Hitesh Bhandari, Helen Johnson, Andriy Moshyk, Srividya KotapatiAdditional file 2. Unit cost of key resources (2017).